Skip to content
BetaVoices
BetaVoices

CNBC news

Read verified news on BetaVoices covering CNBC, with reporting, context, and related developments.

CNBC Clear filters
Novo says higher-dose Wegovy drove nearly 28% weight loss in some patients

Obesity drugs

Novo says higher-dose Wegovy drove nearly 28% weight loss in some patients

The new analysis comes a month after the 7.2-milligram Wegovy dose launched in the U.S., as Novo Nordisk works to compete more directly with Eli Lilly’s Zepbound

May 12, 2026